Separate three decisions
The medication, the prescribing service and the payment arrangement are related, but they are different decisions. A clinician assesses treatment suitability. You can still compare practical matters such as communication, pharmacy arrangements, fees and cancellation.
Understand the product
Semaglutide and tirzepatide are peptide medicines. Brand names, indications, routes and approved formulations matter. Do not assume that a medicine approved for one use carries an approval for every use. Orforglipron is a non-peptide GLP-1 medicine; being in the GLP-1 category does not make every drug a peptide.
Make room for follow-up
Before enrollment, find out how the clinical team handles questions, reviews progress and authorizes refills. A delivery subscription is not a substitute for a clear care relationship. When comparing services, write down what each one promises and which details still need confirmation.
Use these questions with a licensed clinician. Availability, suitability and price depend on your circumstances.
Explore the next stepSources & reading
FDA: concerns with unapproved GLP-1 drugsNIDDK: prescription medicines for weight managementProvider facts draw on official information checked October 12, 2026. See individual reviews for provider sources.